Alaunos Therapeutics reported $595K in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Alaunos Therapeutics USD 595K 218K Mar/2026
Amgen USD 25.5B 547M Jun/2026
AstraZeneca USD 31.55B 1.02B Jun/2026
Baxter International USD 3.59B 102M Jun/2026
Biogen USD 3.92B 918.2M Jun/2026
Bioline Rx USD 13.62M 1.5M Mar/2026
Bristol-Myers Squibb USD 18.66B 499M Jun/2026
Celltrion KRW 292.71B 9.09B Mar/2026
Corcept Therapeutics USD 153.8M 4.62M Jun/2026
Cspc Pharmaceutical CNY 10.18B 65.36M Dec/2025
Curis USD 14.97M 898K Mar/2026
Deva Holding AS TRY 6.43B 1.18B Sep/2023
Dianthus Therapeutics USD 34.39M 3.89M Jun/2026
Divis Laboratories Ltd INR 20.43B 3.15B Mar/2026
Gilead Sciences USD 11.02B 1.54B Jun/2026
GlaxoSmithKline GBP 21.53B 895M Jun/2026
Incyte USD 1.31B 177.55M Jun/2026
Intrexon USD 23.02M 38K Jun/2024
Ionis Pharmaceuticals USD 315.64M 401.36M Jun/2026
J&J USD 54.9B 2.82B Jun/2026
Kangmei Pharma CNY 5.38B 433.79M Mar/2026
Karyopharm Therapeutics USD 117.3M 25.24M Mar/2026
Knight Therapeutics CAD 165.26M 12.58M Dec/2025
Laboratorios Farma EUR 199.84M 121.75M Dec/2023
Malin Corporation EUR 1000K 500K Dec/2024
Medical Developments International AUD 5.56M 2.26M Dec/2025
Merck USD 27.73B 786M Jun/2026
Neuren Pharmaceuticals AUD 4.34M 3.58M Dec/2025
Novartis USD 31.75B 374M Jun/2026
Organigram Holdings CAD 88.74M 5.31M Mar/2026
Ovoca Bio EUR 1.3M 1.11M Dec/2025
Pfizer USD 32.65B 1.7B Jun/2026
Pharma Mar EUR 98.42M 9.2M Jun/2026
PTC Therapeutics USD 771.07M 152.54M Jun/2026
Qiagen NV USD 581.45M 102.34M Jun/2026
Regeneron Pharmaceuticals USD 5.53B 422.9M Jun/2026
Roche Holding CHF 28.85B 846M Jun/2026
Sangamo BioSciences USD 47.66M 1.9M Jun/2025
Sartorius EUR 1.44B 668.7M Jun/2026
Sino Biopharmaceutical CNY 24.85B 5.29B Jun/2025
TG Therapeutics USD 268.49M 81.38M Jun/2026
Tilray USD 259.32M 8.32M Sep/2025
Verastem USD 66.84M 5.42M Mar/2026
Zealand Pharma A/S 404M 260.96M Mar/2026
Zz Pientze Pharmaceu CNY 2.28B 134.52M Mar/2026